Drug efficacy is typically measured through clinical trials. These trials are often conducted in multiple phases to assess the drug's performance. Phase I trials focus on safety, Phase II on efficacy and optimal dosing, and Phase III on comparing the new drug to existing treatments. The primary measure of efficacy is often the clinical endpoint, which could be symptom improvement, disease remission, or survival rates.
